TY - JOUR
T1 - Muscular G9a regulates muscle-liver-fat axis by musclin under overnutrition in female mice
AU - Zhang, Wenquan
AU - Yang, Dong
AU - Yuan, Yangmian
AU - Liu, Chong
AU - Chen, Hong
AU - Zhang, Yu
AU - Wang, Qing
AU - Petersen, Robert B.
AU - Huang, Kun
AU - Zheng, Ling
N1 - Funding Information:
This work is supported by the National Natural Science Foundation of China (91957114 and 32021003) and the National Key R&D Program of China (2018YFA0800700 and 2019YFA0802701).
Funding Information:
Acknowledgments. The authors thank the Analytical and Testing Core of College of Life Sciences of Wuhan University as well as the Analytical and Testing Center of Huazhong University of Science and Technology for technical assistance. Funding. This work is supported by the National Natural Science Foundation of China (91957114 and 32021003) and the National Key R&D Program of China (2018YFA0800700 and 2019YFA0802701). Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. W.Z., K.H., and L.Z. designed the research. W.Z., D.Y., Y.Y., C.L., H.C., Y.Z., and Q.W. performed the experiments. W.Z., R.B.P., K.H., and L.Z. analyzed the data and wrote the manuscript. L.Z. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Publisher Copyright:
© 2020 by the American Diabetes Association.
PY - 2020/12
Y1 - 2020/12
N2 - Cross talk among different tissues and organs is a hotspot in metabolic research. Recent studies have revealed the regulatory roles of a number of myokines in metabolism. Here, we report that female mice lacking muscle-specific histone methylase G9a (Ehmt2Ckmm knockout [KO] or Ehmt2HSA KO)areresistanttohigh-fatdiet(HFD)-induced obesity and hepatic steatosis. Furthermore, we identified asignificantly upregulated circulating level of musclin, a myokine, in HFD-fed Ehmt2Ckmm KO or Ehmt2HSA KO female mice. Similarly, upregulated musclin was observed in mice injected with two structurally different inhibitors for G9a methylase activity: BIX01294 and A366. Moreover, injection of recombinant full-length musclin or its functional core domain inhibited the HFD-induced obesity and hepatic steatosis in wild-type female and male mice. Mechanistically, G9a methylase activity-dependently regulated muscular musclin level by binding to its promoter, also by regulating phosphorylated-FOXO1/FOXO1 levels in vivo and in vitro. Collectively, these data suggest a critical role for G9a in the muscle-liver-fat metabolic axis, at least for female mice. Musclin may serve as a potential therapeutic candidate for obesity and associated diseases.
AB - Cross talk among different tissues and organs is a hotspot in metabolic research. Recent studies have revealed the regulatory roles of a number of myokines in metabolism. Here, we report that female mice lacking muscle-specific histone methylase G9a (Ehmt2Ckmm knockout [KO] or Ehmt2HSA KO)areresistanttohigh-fatdiet(HFD)-induced obesity and hepatic steatosis. Furthermore, we identified asignificantly upregulated circulating level of musclin, a myokine, in HFD-fed Ehmt2Ckmm KO or Ehmt2HSA KO female mice. Similarly, upregulated musclin was observed in mice injected with two structurally different inhibitors for G9a methylase activity: BIX01294 and A366. Moreover, injection of recombinant full-length musclin or its functional core domain inhibited the HFD-induced obesity and hepatic steatosis in wild-type female and male mice. Mechanistically, G9a methylase activity-dependently regulated muscular musclin level by binding to its promoter, also by regulating phosphorylated-FOXO1/FOXO1 levels in vivo and in vitro. Collectively, these data suggest a critical role for G9a in the muscle-liver-fat metabolic axis, at least for female mice. Musclin may serve as a potential therapeutic candidate for obesity and associated diseases.
UR - http://www.scopus.com/inward/record.url?scp=85096516608&partnerID=8YFLogxK
U2 - 10.2337/db20-0437
DO - 10.2337/db20-0437
M3 - Article
C2 - 32994276
AN - SCOPUS:85096516608
SN - 0012-1797
VL - 69
SP - 2642
EP - 2654
JO - Diabetes
JF - Diabetes
IS - 12
ER -